Followers | 261 |
Posts | 51218 |
Boards Moderated | 16 |
Alias Born | 08/29/2007 |
Friday, December 22, 2023 8:57:21 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent TSVT News
- 2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million • Business Wire • 06/26/2024 08:11:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 10:53:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 10:53:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 10:52:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:26:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 11:16:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 11:16:14 PM
- 2seventy bio to Participate in Upcoming Investor Conferences • Business Wire • 05/23/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 10:40:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:03:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:09:06 AM
- 2seventy bio Reports First Quarter Financial Results and Recent Operational Progress • Business Wire • 05/08/2024 11:00:00 AM
- 2seventy bio to Report First Quarter 2024 Financial Results on May 8, 2024 • Business Wire • 05/03/2024 11:00:00 AM
- U.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy • Business Wire • 04/05/2024 01:05:00 PM
- 2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron • Business Wire • 04/01/2024 11:30:00 AM
- 2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors • Business Wire • 03/20/2024 09:04:00 PM
- FDA Advisory Committee Votes in Favor of Bristol Myers Squibb’s and 2seventy bio’s Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy • Business Wire • 03/15/2024 10:27:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:02:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:03:51 PM
- 2seventy bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Progress • Business Wire • 03/05/2024 12:00:00 PM
- 2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences • Business Wire • 03/01/2024 12:00:00 PM
- 2seventy bio to Participate in Upcoming Investor Conferences • Business Wire • 02/05/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 12:02:03 PM
- Bristol Myers Squibb and 2seventy bio Share Update on U.S. FDA Oncologic Drugs Advisory Committee Meeting for Abecma in Triple-Class Exposed Multiple Myeloma Based on KarMMa-3 Study • Business Wire • 02/05/2024 11:59:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/02/2024 09:54:43 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM